>

Monoclonal antibodies (mab) to human CD14

cat. no

mab

isotype

CD14 epitope

characteristics

021-1

biG 10

IgG1

amino acid (aa) 9-13,
aa 39-44

inhibits LPS-binding to CD14

021-2

biG 13

IgG1

aa 9-13, aa 39-44

inhibits LPS-binding to CD14

021-3

biG 14

IgG2a

aa 39-44

inhibits LPS-binding to CD14

021-4

biG 2
(RoMo1)

IgG2a

aa 147-152

no inhibition of LPS-binding to CD14

021-5

biG 4

IgG1

aa 33-44

no inhibition of LPS-binding to CD14

021-6

biG 7

IgG1

beyond N-terminal
aa 1-152

no inhibition of LPS-binding to CD14

Antibody preparation

cat. no

antibody preparation

size

c

protein G purified IgG

0.1 mg

Downloads

References

Stelter, F. et al. (1996): The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur. J. Biochem. 236, 457-464

 

F. Stelter et al. Eur. J. Biochem 243, 100-109, 1997

Dziarski.R. Tapping,R.I. Tobias P.S. et al Binding of bacterial Peptidoglycan to CD14, J. Biol Chem.1998,273(15) 8680-8690

 

Vanlandschoot, P. Van Houtte,F. Roobrouck,A. Farhoudi,A. et al. LPS-binding protein an CD14-dependent attachment of hepatitis B Surface antigen to monocytes is determined by the phospholipid moity of the particles. J of General Virology 2002, 83:2279-2289

 

Vanlandshoot, P., F. van Houtte, P. Ulrichs, J. Tavemier, G. Leroux-Roel Immunostimulatory potential of hepatitis B nucleocapsid preparations:Lipopolysaccharide contamination should not be overlooked J. of General Virology 2005, 86:323.331

 

Lührmann,A. Thölke J. Schumann,J. et al Immunomodulating Properties of the antibiotic Novobiocin in Human Monocytes, Antimicrobial Agents and Chemo-therapy 1998,42(8):1911-1916

 

  Sitemap   Print   Top
  Imprint